Overview

* US Physical Therapy ( USPH ) Q2 revenue from physical therapy operations rises 17.3% driven by record patient visits

* Adjusted EBITDA for Q2 beats analyst expectations, rising 21.4% to $26.9 mln

* Company raises full-year 2025 earnings guidance, reflecting strong performance

Outlook

* Company raises full-year 2025 Adjusted EBITDA guidance to $93.0 mln-$97.0 mln

* Company expects continued growth in injury prevention services

Result Drivers

* RECORD PATIENT VISITS - US Physical Therapy reports all-time high of 1,558,756 patient visits in Q2 2025, a 16.7% increase from Q2 2024

* CLINIC EXPANSION - Co added six clinics and acquired equity interests in new practices, contributing to revenue growth

* IIP GROWTH - Industrial injury prevention services revenue rose 22.6% to $29.1 mln, driven by organic growth and acquisitions, per CEO Chris Reading

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 EPS $0.58

Q2 Net $12.40

Income mln

Q2 Beat $26.90 $24.50

Adjusted mln mln (7

EBITDA Analysts

)

Q2 $0.45

Dividend

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the healthcare facilities & services peer group is "buy"

* Wall Street's median 12-month price target for US Physical Therapy Inc ( USPH ) is $107.00, about 32.1% above its August 6 closing price of $72.69

* The stock recently traded at 27 times the next 12-month earnings vs. a P/E of 26 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)